The Discounted Cash Flow (DCF) valuation of Oramed Pharmaceuticals Inc (ORMP) is (35.95) USD. With the latest stock price at 4.74 USD, the upside of Oramed Pharmaceuticals Inc based on DCF is -858.5%.
Based on the latest price of 4.74 USD and our DCF valuation, Oramed Pharmaceuticals Inc (ORMP) is a sell. selling ORMP stocks now will result in a potential gain of 858.5%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 6.4% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (255.76) - (19.76) | (35.95) |
| Upside | -5495.8% - -517.0% | -858.5% |